18
Views
0
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Oral isotretinoin: intermittent and low-dosage regimen in acne

&
Pages 267-269 | Published online: 10 Jan 2014

References

  • Ellis CN, Krach KJ. Uses and complications of isotretinoin therapy. J. Am. Acad. Dermatol.45(5), S150–S157 (2001). Comment in: J. Am. Acad. Dermatol.48(2), 306–308 (2003).
  • Ramos-e-Silva M, Carneiro S, Ponzio H et al. Estudo multicêntrico aberto da eficácia e tolerabilidade do adapaleno 0,1% gel em pacientes de acne vulgar. An. Bras Dermatol.78(2), 155–168 (2003).
  • Reis C. Oral retinoid in the treatment of acne. Exp. Rev. Dermatol.1(1), 173–175 (2006).
  • Torras H. Retinoids in aging. Clin. Dermatol.14(2), 207–215 (1996).
  • Tur E. Disorders of the sebaceous, apocrine and eccrine glands. In: Women’s Dermatology from Infancy to Maturity. Parish LC, Brenner S, Ramos-e-Silva M (Eds). Parthenon, NY 109–120 (2001).
  • Zaenglein AL, Thiboutot DM. Acne vulgaris. In: Dermatology. Bolognia JL, Jorizzo JL, Rapini RP (Eds). Mosby, London 531–544 (2003).
  • Layton AM, Dreno B, Gollnick HP, Zouboulis CC. A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris. J. Eur. Acad. Dermatol. Venereol.20(7), 773–776 (2006).
  • Kaymark Y, Ilter N. The effectiveness of intermittent isotretinoin treatment in mild or moderate acne. J. Eur. Acad. Dermatol. Venereol.20, 1256–1260 (2006).
  • Burke BM, Cunliffe WJ. The assessment of acne vulgaris – the Leeds technique. Br. J. Dermatol.111, 83–92 (1984).
  • Zouboulis CC. Retinoids – which dermatological indications will benefit in the near future? Skin Pharmacol. Appl. Skin Physiol.14(5), 303–315 (2001).
  • Schenfeld N. Schools of pharmacology: retinoid update. J. Drugs Dermatol.5(9), 921–922 (2006).
  • Dreno B, Bettoli V, Ochsendorf F et al. An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations. Eur. J. Dermatol.16(5), 565–571 (2006).
  • Zane LT, Leyden WA, Marqueling AL, Manos MM. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. Arch. Dermatol.142, 1016–1022 (2006).
  • Hermes B, Praetel C, Henz BM. Medium dose isotretinoin for the treatment of acne. J. Eur. Acad. Dermatol. Venereol.11, 117–121 (1998).
  • Kockaert N, Neumann M. Systemic and topical drugs for aging skin. J. Drugs Dermatol.2(4), 435–441 (2003).
  • Glasser DA, Rogers C. Topical and systemic therapies for the aging face. Facial Plastic Surg. Clin. N. Am.9(2), 189–196 (2001).
  • Ghaffarpour G, Mazloomi S, Soltani-Arabshahi R, Seyed KS. Oral isotretinoin for acne, adjusting treatment according to patient’s response. J. Drugs Dermatol.5(9), 878–882 (2006).
  • Ramos-e-Silva M, Carneiro SCS. Classification of acne. Expert Rev. Dermatol.1(1), 157–159 (2006).
  • Ramos-e-Silva M, Brazilian Acne Group. What is the consensus and algorithm for the treatment of acne? Expert Rev. Dermatol.1(1), 185–186 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.